Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma

To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 39; no. 1; p. 110639
Main Authors Altorki, Nasser K., Borczuk, Alain C., Harrison, Sebron, Groner, Lauren K., Bhinder, Bhavneet, Mittal, Vivek, Elemento, Olivier, McGraw, Timothy E.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 05.04.2022
Elsevier
Subjects
Online AccessGet full text
ISSN2211-1247
2211-1247
DOI10.1016/j.celrep.2022.110639

Cover

Loading…
Abstract To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive cancers. Profiling data reveal a dynamic interaction between the tumor and its TME throughout progression. Alterations in genes regulating the extracellular matrix and genes regulating fibroblasts are central at the preinvasive state. T cell-mediated immune suppression is initiated in preinvasive nodules and sustained with rising intensity through progression to invasive tumors. Reduced T cell infiltration of the cancer cell nests is more frequently associated with preinvasive cancers, possibly until tumor evolution leads to a durable, viable invasive phenotype accompanied by more varied and robust immune suppression. Upregulation of immune checkpoints occurs only in the invasive nodules. Throughout progression, an effector immune response is present but is effectively thwarted by the immune-suppressive elements. [Display omitted] •Non-solid CT density lung adenocarcinomas are predominantly pre/minimally invasive•Immune-suppressive Tregs are increased in non-solid nodules•ECM genes are increased in non-solid nodules, implicating fibroblasts activation•Increased immune suppression parallels progression to invasion CT-scan-identified lung nodules present a significant clinical challenge. Altorki et al. define characteristics, both immune-context and microenvironment features, distinguishing normal lung, preinvasive, and invasive nodules. By capturing early features of disease progression, they inform future interception strategies and identify key questions to be investigated in mechanistic studies.
AbstractList To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive cancers. Profiling data reveal a dynamic interaction between the tumor and its TME throughout progression. Alterations in genes regulating the extracellular matrix and genes regulating fibroblasts are central at the preinvasive state. T cell-mediated immune suppression is initiated in preinvasive nodules and sustained with rising intensity through progression to invasive tumors. Reduced T cell infiltration of the cancer cell nests is more frequently associated with preinvasive cancers, possibly until tumor evolution leads to a durable, viable invasive phenotype accompanied by more varied and robust immune suppression. Upregulation of immune checkpoints occurs only in the invasive nodules. Throughout progression, an effector immune response is present but is effectively thwarted by the immune-suppressive elements. CT-scan-identified lung nodules present a significant clinical challenge. Altorki et al. define characteristics, both immune-context and microenvironment features, distinguishing normal lung, preinvasive, and invasive nodules. By capturing early features of disease progression, they inform future interception strategies and identify key questions to be investigated in mechanistic studies.
To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive cancers. Profiling data reveal a dynamic interaction between the tumor and its TME throughout progression. Alterations in genes regulating the extracellular matrix and genes regulating fibroblasts are central at the preinvasive state. T cell-mediated immune suppression is initiated in preinvasive nodules and sustained with rising intensity through progression to invasive tumors. Reduced T cell infiltration of the cancer cell nests is more frequently associated with preinvasive cancers, possibly until tumor evolution leads to a durable, viable invasive phenotype accompanied by more varied and robust immune suppression. Upregulation of immune checkpoints occurs only in the invasive nodules. Throughout progression, an effector immune response is present but is effectively thwarted by the immune-suppressive elements.
To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive cancers. Profiling data reveal a dynamic interaction between the tumor and its TME throughout progression. Alterations in genes regulating the extracellular matrix and genes regulating fibroblasts are central at the preinvasive state. T cell-mediated immune suppression is initiated in preinvasive nodules and sustained with rising intensity through progression to invasive tumors. Reduced T cell infiltration of the cancer cell nests is more frequently associated with preinvasive cancers, possibly until tumor evolution leads to a durable, viable invasive phenotype accompanied by more varied and robust immune suppression. Upregulation of immune checkpoints occurs only in the invasive nodules. Throughout progression, an effector immune response is present but is effectively thwarted by the immune-suppressive elements.To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive cancers. Profiling data reveal a dynamic interaction between the tumor and its TME throughout progression. Alterations in genes regulating the extracellular matrix and genes regulating fibroblasts are central at the preinvasive state. T cell-mediated immune suppression is initiated in preinvasive nodules and sustained with rising intensity through progression to invasive tumors. Reduced T cell infiltration of the cancer cell nests is more frequently associated with preinvasive cancers, possibly until tumor evolution leads to a durable, viable invasive phenotype accompanied by more varied and robust immune suppression. Upregulation of immune checkpoints occurs only in the invasive nodules. Throughout progression, an effector immune response is present but is effectively thwarted by the immune-suppressive elements.
To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive cancers. Profiling data reveal a dynamic interaction between the tumor and its TME throughout progression. Alterations in genes regulating the extracellular matrix and genes regulating fibroblasts are central at the preinvasive state. T cell-mediated immune suppression is initiated in preinvasive nodules and sustained with rising intensity through progression to invasive tumors. Reduced T cell infiltration of the cancer cell nests is more frequently associated with preinvasive cancers, possibly until tumor evolution leads to a durable, viable invasive phenotype accompanied by more varied and robust immune suppression. Upregulation of immune checkpoints occurs only in the invasive nodules. Throughout progression, an effector immune response is present but is effectively thwarted by the immune-suppressive elements. [Display omitted] •Non-solid CT density lung adenocarcinomas are predominantly pre/minimally invasive•Immune-suppressive Tregs are increased in non-solid nodules•ECM genes are increased in non-solid nodules, implicating fibroblasts activation•Increased immune suppression parallels progression to invasion CT-scan-identified lung nodules present a significant clinical challenge. Altorki et al. define characteristics, both immune-context and microenvironment features, distinguishing normal lung, preinvasive, and invasive nodules. By capturing early features of disease progression, they inform future interception strategies and identify key questions to be investigated in mechanistic studies.
ArticleNumber 110639
Author Elemento, Olivier
Bhinder, Bhavneet
Mittal, Vivek
McGraw, Timothy E.
Groner, Lauren K.
Harrison, Sebron
Borczuk, Alain C.
Altorki, Nasser K.
AuthorAffiliation 4 Department of Pathology, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
3 Meyer Cancer Center, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
9 Senior author
10 Lead contact
1 Department of Cardiothoracic Surgery, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
2 Neuberger Berman Foundation Lung Cancer Research Center, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
8 Department of Biochemistry, Weill Cornell Medicine, New York, NY 10068, USA
5 Department of Radiology, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
6 Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10068, USA
7 Department of Cell Biology, Weill Cornell Medicine New York, NY 10068, USA
AuthorAffiliation_xml – name: 5 Department of Radiology, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– name: 9 Senior author
– name: 6 Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10068, USA
– name: 7 Department of Cell Biology, Weill Cornell Medicine New York, NY 10068, USA
– name: 2 Neuberger Berman Foundation Lung Cancer Research Center, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– name: 3 Meyer Cancer Center, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– name: 1 Department of Cardiothoracic Surgery, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– name: 10 Lead contact
– name: 4 Department of Pathology, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– name: 8 Department of Biochemistry, Weill Cornell Medicine, New York, NY 10068, USA
Author_xml – sequence: 1
  givenname: Nasser K.
  surname: Altorki
  fullname: Altorki, Nasser K.
  email: nkaltork@med.cornell.edu
  organization: Department of Cardiothoracic Surgery, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– sequence: 2
  givenname: Alain C.
  orcidid: 0000-0001-6807-8064
  surname: Borczuk
  fullname: Borczuk, Alain C.
  organization: Meyer Cancer Center, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– sequence: 3
  givenname: Sebron
  surname: Harrison
  fullname: Harrison, Sebron
  organization: Department of Cardiothoracic Surgery, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– sequence: 4
  givenname: Lauren K.
  surname: Groner
  fullname: Groner, Lauren K.
  organization: Department of Radiology, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– sequence: 5
  givenname: Bhavneet
  surname: Bhinder
  fullname: Bhinder, Bhavneet
  organization: Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10068, USA
– sequence: 6
  givenname: Vivek
  surname: Mittal
  fullname: Mittal, Vivek
  organization: Department of Cardiothoracic Surgery, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– sequence: 7
  givenname: Olivier
  surname: Elemento
  fullname: Elemento, Olivier
  organization: Meyer Cancer Center, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
– sequence: 8
  givenname: Timothy E.
  orcidid: 0000-0001-9748-263X
  surname: McGraw
  fullname: McGraw, Timothy E.
  email: temcgraw@med.cornell.edu
  organization: Department of Cardiothoracic Surgery, Weill Cornell Medicine and NY Presbyterian Hospital, New York, NY 10068, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35385730$$D View this record in MEDLINE/PubMed
BookMark eNqFks1u1DAUhSNUREvpGyCUJZsZ_JMfmwUSqqBUqsQG1taNfTPjUWIPtpOKV-Cp8TTT0rIAb3xl3_Nd6Z7zsjhx3mFRvKZkTQlt3u3WGoeA-zUjjK0pJQ2Xz4ozxihdUVa1J4_q0-Iixh3JpyGUyupFccprLuqWk7Pi19XgOxhKnP0wJetd6fsybbFM0-hDOVodPLrZBu9GdKmEGL22kNCUtzZty33wm4AxHpR98GN-QOtmiHbG8qFI_k-9nUZw5TC5TQkGndcQtHV-hFfF8x6GiBfH-7z4_vnTt8svq5uvV9eXH29WumYyrTqOBmppaC849j3vGoPGSIlNrQkTpNUGKXRCE1FhzXuApgPZUi00SikYPy-uF67xsFP7YEcIP5UHq-4efNgoCMnqARVtuaZ3UJRV10tBOsZES6TUjAAzmfVhYe2nbkSj84oCDE-gT3-c3aqNn5UknLNaZMDbIyD4HxPGpEYbs7cDOPRTVKypBGka2src-ubxrIch92bmhvdLQ_YsxoC90jbBwdQ82g6KEnUIj9qpJTzqEB61hCeLq7_E9_z_yI4LwOzYbDGoqC06jcYG1Cmv1P4b8Bs7MeUc
CitedBy_id crossref_primary_10_1016_j_mcp_2024_101971
crossref_primary_10_1016_j_acra_2024_02_011
crossref_primary_10_1016_j_celrep_2022_111596
crossref_primary_10_1245_s10434_023_14048_4
crossref_primary_10_1038_s41568_025_00791_1
crossref_primary_10_1111_1759_7714_15380
crossref_primary_10_1016_j_ebiom_2023_104728
crossref_primary_10_1186_s12890_023_02310_0
crossref_primary_10_3389_fimmu_2023_1176594
crossref_primary_10_31083_j_fbl2906204
crossref_primary_10_3390_cells12071048
crossref_primary_10_1007_s00432_022_04289_3
crossref_primary_10_1002_adhm_202302246
crossref_primary_10_1073_pnas_2420502122
crossref_primary_10_3389_fonc_2024_1380527
crossref_primary_10_1002_ctm2_1391
crossref_primary_10_1016_j_jtcvs_2022_10_011
crossref_primary_10_1186_s13046_023_02753_7
crossref_primary_10_1164_rccm_202406_1168ST
crossref_primary_10_1016_j_heliyon_2024_e37412
crossref_primary_10_1038_s41467_022_35584_9
crossref_primary_10_1186_s12890_024_03072_z
Cites_doi 10.1038/s41467-019-13460-3
10.1158/2159-8290.CD-17-0222
10.1172/JCI45817
10.1158/2159-8290.CD-19-1366
10.1186/s13059-017-1349-1
10.1016/j.tcb.2014.11.006
10.1093/nar/gky1038
10.1038/s41467-020-18794-x
10.1007/s12072-018-9850-5
10.1038/nri3902
10.1172/jci.insight.95692
10.1093/nar/gkaa1113
10.3390/ijms20030593
10.1053/j.gastro.2015.04.010
10.1073/pnas.1014506108
10.1016/j.cell.2017.04.014
10.1038/nature25492
10.1038/nm.3337
10.1158/2326-6066.CIR-18-0439
10.1073/pnas.1300136110
10.1016/j.immuni.2018.03.014
10.3389/fonc.2019.01370
10.3390/ijms20092256
10.1172/jci.insight.87030
10.3389/fmolb.2019.00160
10.1038/s41568-019-0238-1
10.1093/annonc/mdx727
10.4049/jimmunol.181.3.1806
10.1038/s41591-018-0323-0
10.1186/s13045-020-01027-5
10.1126/science.aaa6204
10.1165/rcmb.2018-0313OC
10.1007/978-1-4939-7493-1_12
10.1016/j.celrep.2019.11.113
10.1164/rccm.201902-0294OC
10.1038/s41467-021-22890-x
10.1038/75556
10.1158/0008-5472.CAN-19-0153
10.1038/s41392-021-00544-0
10.1038/ncomms9258
10.1016/S0002-9440(10)65271-6
10.1007/s10549-015-3286-6
10.3390/cancers13143466
10.1038/s41586-019-1330-0
10.1038/s41467-019-10877-8
ContentType Journal Article
Copyright 2022 The Author(s)
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2022 The Author(s)
– notice: Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1016/j.celrep.2022.110639
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2211-1247
EndPage 110639
ExternalDocumentID oai_doaj_org_article_173c102807e94bf980b2287099c20a2d
PMC9033258
35385730
10_1016_j_celrep_2022_110639
S2211124722003916
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: UG3 CA244697
– fundername: NCI NIH HHS
  grantid: U54 CA272688
– fundername: NCATS NIH HHS
  grantid: UL1 TR002384
– fundername: NCI NIH HHS
  grantid: UH3 CA244697
– fundername: NCI NIH HHS
  grantid: R01 CA194547
GroupedDBID 0R~
0SF
4.4
457
53G
5VS
6I.
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AAKRW
AALRI
AAUCE
AAXUO
ABMAC
ABMWF
ACGFO
ACGFS
ADBBV
ADEZE
AENEX
AEXQZ
AFTJW
AGHFR
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BCNDV
DIK
EBS
EJD
FCP
FDB
FRP
GROUPED_DOAJ
GX1
IXB
KQ8
M41
M48
NCXOZ
O-L
O9-
OK1
RCE
ROL
SSZ
AAMRU
AAYWO
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AIGII
AKBMS
AKRWK
AKYEP
APXCP
CITATION
HZ~
IPNFZ
RIG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c529t-b3eda59d1f83eff3b6dedd99e65c02807cde1ab8c084e53faa6ba971c8ce99823
IEDL.DBID M48
ISSN 2211-1247
IngestDate Wed Aug 27 01:19:32 EDT 2025
Thu Aug 21 13:32:34 EDT 2025
Fri Jul 11 02:55:58 EDT 2025
Tue Jul 22 01:42:00 EDT 2025
Tue Jul 01 02:59:26 EDT 2025
Thu Apr 24 23:03:57 EDT 2025
Tue Jul 25 20:58:06 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords lung ground glass lesions
Tregs
CP: Cancer
tumor microenvironment
CT scan density
GGO
extracellular matrix
preinvasive lung adenocarcinoma
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c529t-b3eda59d1f83eff3b6dedd99e65c02807cde1ab8c084e53faa6ba971c8ce99823
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
N.K.A. conceptualized the project, contributed to experimental design, performed analysis and interpretations, and wrote the manuscript. A.C.B. contributed to experimental design and data analyses and edited the manuscript. S.H. reviewed and scored the CT data. L.G. reviewed and scored the CT data. B.B. contributed to analyses of the RNA-seq data. V.M. contributed to experimental design and edited the manuscript. O.E. contributed to experimental design and edited the manuscript. T.E.M. conceptualized the project, contributed to experimental design, performed analysis and interpretation, and wrote the manuscript
AUTHOR CONTRIBUTIONS
ORCID 0000-0001-9748-263X
0000-0001-6807-8064
OpenAccessLink https://doaj.org/article/173c102807e94bf980b2287099c20a2d
PMID 35385730
PQID 2648066179
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_173c102807e94bf980b2287099c20a2d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9033258
proquest_miscellaneous_2648066179
pubmed_primary_35385730
crossref_citationtrail_10_1016_j_celrep_2022_110639
crossref_primary_10_1016_j_celrep_2022_110639
elsevier_sciencedirect_doi_10_1016_j_celrep_2022_110639
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-04-05
PublicationDateYYYYMMDD 2022-04-05
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-05
  day: 05
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell reports (Cambridge)
PublicationTitleAlternate Cell Rep
PublicationYear 2022
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Sanchez-Paulete, Teijeira, Cueto, Garasa, Perez-Gracia, Sanchez-Arraez, Sancho, Melero (bib35) 2017; 28
Dejima, Hu, Chen, Zhang, Fujimoto, Parra, Haymaker, Hubert, Duose, Solis (bib9) 2021; 12
Sun, Mezzadra, Schumacher (bib37) 2018; 48
Winkler, Abisoye-Ogunniyan, Metcalf, Werb (bib42) 2020; 11
Gil Del Alcazar, Huh, Ekram, Trinh, Liu, Beca, Zi, Kwak, Bergholtz, Su (bib13) 2017; 7
Pennycuick, Teixeira, AbdulJabbar, Raza, Lund, Akarca, Rosenthal, Kalinke, Chandrasekharan, Pipinikas (bib28) 2020; 10
Ballester, Milara, Cortijo (bib3) 2019; 20
Navab, Strumpf, Bandarchi, Zhu, Pintilie, Ramnarine, Ibrahimov, Radulovich, Leung, Barczyk (bib25) 2011; 108
Sood, Miller, Brogi, Sui, Armenia, McDonough, Santamaria-Pang, Carlin, Stamper, Campos (bib36) 2016; 1
Yi, Niu, Xu, Luo, Wu (bib45) 2021; 14
Qian, Zhao, Zou, Rahman, Senosain, Stricker, Chen, Powell, Borczuk, Massion (bib31) 2020; 201
Lavin, Kobayashi, Leader, Amir, Elefant, Bigenwald, Remark, Sweeney, Becker, Levine (bib22) 2017; 169
Tang, Teijaro, Njau, Chandran, Azimzadeh, Nadler, Rothstein, Farber (bib38) 2008; 181
Pyonteck, Akkari, Schuhmacher, Bowman, Sevenich, Quail, Olson, Quick, Huse, Teijeiro (bib30) 2013; 19
Beatty, Winograd, Evans, Long, Luque, Lee, Clendenin, Gladney, Knoblock, Guirnalda (bib4) 2015; 149
Mascaux, Angelova, Vasaturo, Beane, Hijazi, Anthoine, Buttard, Rothe, Willard-Gallo, Haller (bib23) 2019; 571
Gene Ontology (bib11) 2021; 49
Yaghjyan, Colditz, Rosner, Tamimi (bib44) 2015; 150
Mi, Muruganujan, Ebert, Huang, Thomas (bib24) 2019; 47
Krysan, Tran, Grimes, Fishbein, Seki, Gardner, Walser, Salehi-Rad, Yanagawa, Lee (bib21) 2019; 79
Salmon, Franciszkiewicz, Damotte, Dieu-Nosjean, Validire, Trautmann, Mami-Chouaib, Donnadieu (bib34) 2012; 122
Quintero-Fabian, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argaez, Lara-Riegos, Ramirez-Camacho, Alvarez-Sanchez (bib32) 2019; 9
Hu, Fujimoto, Ying, Fukuoka, Ashizawa, Sun, Reuben, Chow, McGranahan, Chen (bib15) 2019; 10
Peyser, MacDonnell, Gao, Cheng, Kim, Kaplan, Ruan, Wei, Ni, Adler (bib29) 2019; 61
Teixeira, Pipinikas, Pennycuick, Lee-Six, Chandrasekharan, Beane, Morris, Karpathakis, Feber, Breeze (bib40) 2019; 25
Izumchenko, Chang, Brait, Fertig, Kagohara, Bedi, Marchionni, Agrawal, Ravi, Jones (bib17) 2015; 6
Klemm, Joyce (bib19) 2015; 25
Tauriello, Palomo-Ponce, Stork, Berenguer-Llergo, Badia-Ramentol, Iglesias, Sevillano, Ibiza, Canellas, Hernando-Momblona (bib39) 2018; 554
Gerdes, Sevinsky, Sood, Adak, Bello, Bordwell, Can, Corwin, Dinn, Filkins (bib12) 2013; 110
Sahai, Astsaturov, Cukierman, DeNardo, Egeblad, Evans, Fearon, Greten, Hingorani, Hunter (bib33) 2020; 20
Chen, Carrot-Zhang, Zhao, Hu, Freeman, Yu, Ha, Taylor, Berger, Westlake (bib7) 2019; 10
Henke, Nandigama, Ergun (bib14) 2019; 6
Joyce, Fearon (bib18) 2015; 348
Chung, Jo, Chung, Kim (bib8) 2018; 12
Pedros, Canonigo-Balancio, Kong, Altman (bib27) 2017; 2
Chen, Khodadoust, Liu, Newman, Alizadeh (bib6) 2018; 1711
Kobayashi, Mitsudomi (bib20) 2013; 2
Ashburner, Ball, Blake, Botstein, Butler, Cherry, Davis, Dolinski, Dwight, Eppig (bib2) 2000; 25
Belhabib, Zaghdoudi, Lac, Bousquet, Jean (bib5) 2021; 13
Yoshida, Azuma, Miura, Orimo (bib46) 2019; 20
Huang, Zhang, Wan, Zhou, Zheng, Lin, Qiao (bib16) 2021; 6
Turley, Cremasco, Astarita (bib41) 2015; 15
Aran, Hu, Butte (bib1) 2017; 18
Garcia-Diaz, Shin, Moreno, Saco, Escuin-Ordinas, Rodriguez, Zaretsky, Sun, Hugo, Wang (bib10) 2019; 29
Niho, Yokose, Suzuki, Kodama, Nishiwaki, Mukai (bib26) 1999; 154
Xu-Monette, Xiao, Au, Padmanabhan, Xu, Hoe, Rodriguez-Perales, Torres-Ruiz, Manyam, Visco (bib43) 2019; 7
Gene Ontology (10.1016/j.celrep.2022.110639_bib11) 2021; 49
Joyce (10.1016/j.celrep.2022.110639_bib18) 2015; 348
Chung (10.1016/j.celrep.2022.110639_bib8) 2018; 12
Klemm (10.1016/j.celrep.2022.110639_bib19) 2015; 25
Lavin (10.1016/j.celrep.2022.110639_bib22) 2017; 169
Pedros (10.1016/j.celrep.2022.110639_bib27) 2017; 2
Teixeira (10.1016/j.celrep.2022.110639_bib40) 2019; 25
Yi (10.1016/j.celrep.2022.110639_bib45) 2021; 14
Winkler (10.1016/j.celrep.2022.110639_bib42) 2020; 11
Sood (10.1016/j.celrep.2022.110639_bib36) 2016; 1
Sahai (10.1016/j.celrep.2022.110639_bib33) 2020; 20
Izumchenko (10.1016/j.celrep.2022.110639_bib17) 2015; 6
Yaghjyan (10.1016/j.celrep.2022.110639_bib44) 2015; 150
Hu (10.1016/j.celrep.2022.110639_bib15) 2019; 10
Chen (10.1016/j.celrep.2022.110639_bib7) 2019; 10
Quintero-Fabian (10.1016/j.celrep.2022.110639_bib32) 2019; 9
Mascaux (10.1016/j.celrep.2022.110639_bib23) 2019; 571
Krysan (10.1016/j.celrep.2022.110639_bib21) 2019; 79
Niho (10.1016/j.celrep.2022.110639_bib26) 1999; 154
Pennycuick (10.1016/j.celrep.2022.110639_bib28) 2020; 10
Ballester (10.1016/j.celrep.2022.110639_bib3) 2019; 20
Qian (10.1016/j.celrep.2022.110639_bib31) 2020; 201
Sanchez-Paulete (10.1016/j.celrep.2022.110639_bib35) 2017; 28
Garcia-Diaz (10.1016/j.celrep.2022.110639_bib10) 2019; 29
Tang (10.1016/j.celrep.2022.110639_bib38) 2008; 181
Dejima (10.1016/j.celrep.2022.110639_bib9) 2021; 12
Belhabib (10.1016/j.celrep.2022.110639_bib5) 2021; 13
Peyser (10.1016/j.celrep.2022.110639_bib29) 2019; 61
Gil Del Alcazar (10.1016/j.celrep.2022.110639_bib13) 2017; 7
Henke (10.1016/j.celrep.2022.110639_bib14) 2019; 6
Mi (10.1016/j.celrep.2022.110639_bib24) 2019; 47
Tauriello (10.1016/j.celrep.2022.110639_bib39) 2018; 554
Huang (10.1016/j.celrep.2022.110639_bib16) 2021; 6
Xu-Monette (10.1016/j.celrep.2022.110639_bib43) 2019; 7
Yoshida (10.1016/j.celrep.2022.110639_bib46) 2019; 20
Pyonteck (10.1016/j.celrep.2022.110639_bib30) 2013; 19
Sun (10.1016/j.celrep.2022.110639_bib37) 2018; 48
Salmon (10.1016/j.celrep.2022.110639_bib34) 2012; 122
Gerdes (10.1016/j.celrep.2022.110639_bib12) 2013; 110
Kobayashi (10.1016/j.celrep.2022.110639_bib20) 2013; 2
Ashburner (10.1016/j.celrep.2022.110639_bib2) 2000; 25
Aran (10.1016/j.celrep.2022.110639_bib1) 2017; 18
Chen (10.1016/j.celrep.2022.110639_bib6) 2018; 1711
Beatty (10.1016/j.celrep.2022.110639_bib4) 2015; 149
Navab (10.1016/j.celrep.2022.110639_bib25) 2011; 108
Turley (10.1016/j.celrep.2022.110639_bib41) 2015; 15
References_xml – volume: 6
  start-page: 153
  year: 2021
  ident: bib16
  article-title: Extracellular matrix and its therapeutic potential for cancer treatment
  publication-title: Signal. Transduct. Target Ther.
– volume: 1
  start-page: e87030
  year: 2016
  ident: bib36
  article-title: Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism
  publication-title: JCI Insight
– volume: 20
  start-page: 2256
  year: 2019
  ident: bib46
  article-title: Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies
  publication-title: Int. J. Mol. Sci.
– volume: 122
  start-page: 899
  year: 2012
  end-page: 910
  ident: bib34
  article-title: Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
  publication-title: J. Clin. Invest.
– volume: 154
  start-page: 249
  year: 1999
  end-page: 254
  ident: bib26
  article-title: Monoclonality of atypical adenomatous hyperplasia of the lung
  publication-title: Am. J. Pathol.
– volume: 9
  start-page: 1370
  year: 2019
  ident: bib32
  article-title: Role of matrix metalloproteinases in angiogenesis and cancer
  publication-title: Front. Oncol.
– volume: 15
  start-page: 669
  year: 2015
  end-page: 682
  ident: bib41
  article-title: Immunological hallmarks of stromal cells in the tumour microenvironment
  publication-title: Nat. Rev. Immunol.
– volume: 2
  start-page: 354
  year: 2013
  end-page: 363
  ident: bib20
  article-title: Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
  publication-title: Transl. Lung Cancer Res.
– volume: 18
  start-page: 220
  year: 2017
  ident: bib1
  article-title: xCell: digitally portraying the tissue cellular heterogeneity landscape
  publication-title: Genome Biol.
– volume: 7
  start-page: 644
  year: 2019
  end-page: 657
  ident: bib43
  article-title: Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL
  publication-title: Cancer Immunol. Res.
– volume: 149
  start-page: 201
  year: 2015
  end-page: 210
  ident: bib4
  article-title: Exclusion of T Cells from pancreatic carcinomas in mice is regulated by Ly6C(low) F4/80(+) extratumoral macrophages
  publication-title: Gastroenterology
– volume: 29
  start-page: 3766
  year: 2019
  ident: bib10
  article-title: Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression
  publication-title: Cell Rep.
– volume: 181
  start-page: 1806
  year: 2008
  end-page: 1813
  ident: bib38
  article-title: CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis
  publication-title: J. Immunol.
– volume: 110
  start-page: 11982
  year: 2013
  end-page: 11987
  ident: bib12
  article-title: Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue
  publication-title: Proc. Natl. Acad. Sci. U S A.
– volume: 79
  start-page: 5022
  year: 2019
  end-page: 5033
  ident: bib21
  article-title: The immune contexture associates with the genomic landscape in lung adenomatous premalignancy
  publication-title: Cancer Res.
– volume: 108
  start-page: 7160
  year: 2011
  end-page: 7165
  ident: bib25
  article-title: Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer
  publication-title: Proc. Natl. Acad. Sci. U S A
– volume: 10
  start-page: 2978
  year: 2019
  ident: bib15
  article-title: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
  publication-title: Nat. Commun.
– volume: 201
  start-page: 697
  year: 2020
  end-page: 706
  ident: bib31
  article-title: Genomic underpinnings of tumor behavior in in situ and early lung adenocarcinoma
  publication-title: Am. J. Respir. Crit. Care Med.
– volume: 12
  start-page: 269
  year: 2018
  end-page: 276
  ident: bib8
  article-title: Liver cirrhosis and cancer: comparison of mortality
  publication-title: Hepatol. Int.
– volume: 571
  start-page: 570
  year: 2019
  end-page: 575
  ident: bib23
  article-title: Immune evasion before tumour invasion in early lung squamous carcinogenesis
  publication-title: Nature
– volume: 1711
  start-page: 243
  year: 2018
  end-page: 259
  ident: bib6
  article-title: Profiling tumor infiltrating immune cells with CIBERSORT
  publication-title: Methods Mol. Biol.
– volume: 19
  start-page: 1264
  year: 2013
  end-page: 1272
  ident: bib30
  article-title: CSF-1R inhibition alters macrophage polarization and blocks glioma progression
  publication-title: Nat. Med.
– volume: 20
  start-page: 174
  year: 2020
  end-page: 186
  ident: bib33
  article-title: A framework for advancing our understanding of cancer-associated fibroblasts
  publication-title: Nat. Rev. Cancer
– volume: 13
  start-page: 3466
  year: 2021
  ident: bib5
  article-title: Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy?
  publication-title: Cancers (Basel)
– volume: 6
  start-page: 160
  year: 2019
  ident: bib14
  article-title: Extracellular matrix in the tumor microenvironment and its impact on cancer therapy
  publication-title: Front. Mol. Biosci.
– volume: 150
  start-page: 181
  year: 2015
  end-page: 189
  ident: bib44
  article-title: Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors
  publication-title: Breast Cancer Res. Treat
– volume: 2
  start-page: e95692
  year: 2017
  ident: bib27
  article-title: Requirement of Treg-intrinsic CTLA4/PKCeta signaling pathway for suppressing tumor immunity
  publication-title: JCI Insight
– volume: 25
  start-page: 198
  year: 2015
  end-page: 213
  ident: bib19
  article-title: Microenvironmental regulation of therapeutic response in cancer
  publication-title: Trends Cell Biol.
– volume: 10
  start-page: 1489
  year: 2020
  end-page: 1499
  ident: bib28
  article-title: Immune surveillance in clinical regression of preinvasive squamous cell lung cancer
  publication-title: Cancer Discov.
– volume: 348
  start-page: 74
  year: 2015
  end-page: 80
  ident: bib18
  article-title: T cell exclusion, immune privilege, and the tumor microenvironment
  publication-title: Science
– volume: 25
  start-page: 517
  year: 2019
  end-page: 525
  ident: bib40
  article-title: Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
  publication-title: Nat. Med.
– volume: 10
  start-page: 5472
  year: 2019
  ident: bib7
  article-title: Genomic and immune profiling of pre-invasive lung adenocarcinoma
  publication-title: Nat. Commun.
– volume: 61
  start-page: 74
  year: 2019
  end-page: 85
  ident: bib29
  article-title: Defining the activated fibroblast population in lung fibrosis using single-cell sequencing
  publication-title: Am. J. Respir. Cell Mol. Biol.
– volume: 169
  start-page: 750
  year: 2017
  end-page: 765.e17
  ident: bib22
  article-title: Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses
  publication-title: Cell
– volume: 49
  start-page: D325
  year: 2021
  end-page: D334
  ident: bib11
  article-title: The Gene Ontology resource: enriching a GOld mine
  publication-title: Nucleic Acids Res.
– volume: 47
  start-page: D419
  year: 2019
  end-page: D426
  ident: bib24
  article-title: PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
  publication-title: Nucleic Acids Res.
– volume: 554
  start-page: 538
  year: 2018
  end-page: 543
  ident: bib39
  article-title: TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis
  publication-title: Nature
– volume: 20
  start-page: 593
  year: 2019
  ident: bib3
  article-title: Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets
  publication-title: Int. J. Mol. Sci.
– volume: 11
  start-page: 5120
  year: 2020
  ident: bib42
  article-title: Concepts of extracellular matrix remodelling in tumour progression and metastasis
  publication-title: Nat. Commun.
– volume: 6
  start-page: 8258
  year: 2015
  ident: bib17
  article-title: Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
  publication-title: Nat. Commun.
– volume: 7
  start-page: 1098
  year: 2017
  end-page: 1115
  ident: bib13
  article-title: Immune escape in breast cancer during in situ to invasive carcinoma transition
  publication-title: Cancer Discov.
– volume: 48
  start-page: 434
  year: 2018
  end-page: 452
  ident: bib37
  article-title: Regulation and function of the PD-L1 checkpoint
  publication-title: Immunity
– volume: 25
  start-page: 25
  year: 2000
  end-page: 29
  ident: bib2
  article-title: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium
  publication-title: Nat. Genet.
– volume: 12
  start-page: 2722
  year: 2021
  ident: bib9
  article-title: Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features
  publication-title: Nat. Commun.
– volume: 28
  start-page: xii74
  year: 2017
  ident: bib35
  article-title: Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
  publication-title: Ann. Oncol.
– volume: 14
  start-page: 10
  year: 2021
  ident: bib45
  article-title: Regulation of PD-L1 expression in the tumor microenvironment
  publication-title: J. Hematol. Oncol.
– volume: 10
  start-page: 5472
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib7
  article-title: Genomic and immune profiling of pre-invasive lung adenocarcinoma
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13460-3
– volume: 7
  start-page: 1098
  year: 2017
  ident: 10.1016/j.celrep.2022.110639_bib13
  article-title: Immune escape in breast cancer during in situ to invasive carcinoma transition
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-17-0222
– volume: 122
  start-page: 899
  year: 2012
  ident: 10.1016/j.celrep.2022.110639_bib34
  article-title: Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI45817
– volume: 10
  start-page: 1489
  year: 2020
  ident: 10.1016/j.celrep.2022.110639_bib28
  article-title: Immune surveillance in clinical regression of preinvasive squamous cell lung cancer
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-19-1366
– volume: 18
  start-page: 220
  year: 2017
  ident: 10.1016/j.celrep.2022.110639_bib1
  article-title: xCell: digitally portraying the tissue cellular heterogeneity landscape
  publication-title: Genome Biol.
  doi: 10.1186/s13059-017-1349-1
– volume: 25
  start-page: 198
  year: 2015
  ident: 10.1016/j.celrep.2022.110639_bib19
  article-title: Microenvironmental regulation of therapeutic response in cancer
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2014.11.006
– volume: 47
  start-page: D419
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib24
  article-title: PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky1038
– volume: 11
  start-page: 5120
  year: 2020
  ident: 10.1016/j.celrep.2022.110639_bib42
  article-title: Concepts of extracellular matrix remodelling in tumour progression and metastasis
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-18794-x
– volume: 12
  start-page: 269
  year: 2018
  ident: 10.1016/j.celrep.2022.110639_bib8
  article-title: Liver cirrhosis and cancer: comparison of mortality
  publication-title: Hepatol. Int.
  doi: 10.1007/s12072-018-9850-5
– volume: 15
  start-page: 669
  year: 2015
  ident: 10.1016/j.celrep.2022.110639_bib41
  article-title: Immunological hallmarks of stromal cells in the tumour microenvironment
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3902
– volume: 2
  start-page: e95692
  year: 2017
  ident: 10.1016/j.celrep.2022.110639_bib27
  article-title: Requirement of Treg-intrinsic CTLA4/PKCeta signaling pathway for suppressing tumor immunity
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.95692
– volume: 49
  start-page: D325
  year: 2021
  ident: 10.1016/j.celrep.2022.110639_bib11
  article-title: The Gene Ontology resource: enriching a GOld mine
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkaa1113
– volume: 20
  start-page: 593
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib3
  article-title: Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20030593
– volume: 149
  start-page: 201
  year: 2015
  ident: 10.1016/j.celrep.2022.110639_bib4
  article-title: Exclusion of T Cells from pancreatic carcinomas in mice is regulated by Ly6C(low) F4/80(+) extratumoral macrophages
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.04.010
– volume: 108
  start-page: 7160
  year: 2011
  ident: 10.1016/j.celrep.2022.110639_bib25
  article-title: Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer
  publication-title: Proc. Natl. Acad. Sci. U S A
  doi: 10.1073/pnas.1014506108
– volume: 169
  start-page: 750
  year: 2017
  ident: 10.1016/j.celrep.2022.110639_bib22
  article-title: Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses
  publication-title: Cell
  doi: 10.1016/j.cell.2017.04.014
– volume: 554
  start-page: 538
  year: 2018
  ident: 10.1016/j.celrep.2022.110639_bib39
  article-title: TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis
  publication-title: Nature
  doi: 10.1038/nature25492
– volume: 19
  start-page: 1264
  year: 2013
  ident: 10.1016/j.celrep.2022.110639_bib30
  article-title: CSF-1R inhibition alters macrophage polarization and blocks glioma progression
  publication-title: Nat. Med.
  doi: 10.1038/nm.3337
– volume: 7
  start-page: 644
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib43
  article-title: Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-18-0439
– volume: 110
  start-page: 11982
  year: 2013
  ident: 10.1016/j.celrep.2022.110639_bib12
  article-title: Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue
  publication-title: Proc. Natl. Acad. Sci. U S A.
  doi: 10.1073/pnas.1300136110
– volume: 48
  start-page: 434
  year: 2018
  ident: 10.1016/j.celrep.2022.110639_bib37
  article-title: Regulation and function of the PD-L1 checkpoint
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.03.014
– volume: 9
  start-page: 1370
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib32
  article-title: Role of matrix metalloproteinases in angiogenesis and cancer
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2019.01370
– volume: 20
  start-page: 2256
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib46
  article-title: Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20092256
– volume: 1
  start-page: e87030
  year: 2016
  ident: 10.1016/j.celrep.2022.110639_bib36
  article-title: Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.87030
– volume: 6
  start-page: 160
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib14
  article-title: Extracellular matrix in the tumor microenvironment and its impact on cancer therapy
  publication-title: Front. Mol. Biosci.
  doi: 10.3389/fmolb.2019.00160
– volume: 20
  start-page: 174
  year: 2020
  ident: 10.1016/j.celrep.2022.110639_bib33
  article-title: A framework for advancing our understanding of cancer-associated fibroblasts
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0238-1
– volume: 28
  start-page: xii74
  year: 2017
  ident: 10.1016/j.celrep.2022.110639_bib35
  article-title: Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
  publication-title: Ann. Oncol.
  doi: 10.1093/annonc/mdx727
– volume: 181
  start-page: 1806
  year: 2008
  ident: 10.1016/j.celrep.2022.110639_bib38
  article-title: CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.3.1806
– volume: 25
  start-page: 517
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib40
  article-title: Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
  publication-title: Nat. Med.
  doi: 10.1038/s41591-018-0323-0
– volume: 14
  start-page: 10
  year: 2021
  ident: 10.1016/j.celrep.2022.110639_bib45
  article-title: Regulation of PD-L1 expression in the tumor microenvironment
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-020-01027-5
– volume: 348
  start-page: 74
  year: 2015
  ident: 10.1016/j.celrep.2022.110639_bib18
  article-title: T cell exclusion, immune privilege, and the tumor microenvironment
  publication-title: Science
  doi: 10.1126/science.aaa6204
– volume: 61
  start-page: 74
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib29
  article-title: Defining the activated fibroblast population in lung fibrosis using single-cell sequencing
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/rcmb.2018-0313OC
– volume: 1711
  start-page: 243
  year: 2018
  ident: 10.1016/j.celrep.2022.110639_bib6
  article-title: Profiling tumor infiltrating immune cells with CIBERSORT
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-7493-1_12
– volume: 29
  start-page: 3766
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib10
  article-title: Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2019.11.113
– volume: 2
  start-page: 354
  year: 2013
  ident: 10.1016/j.celrep.2022.110639_bib20
  article-title: Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
  publication-title: Transl. Lung Cancer Res.
– volume: 201
  start-page: 697
  year: 2020
  ident: 10.1016/j.celrep.2022.110639_bib31
  article-title: Genomic underpinnings of tumor behavior in in situ and early lung adenocarcinoma
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.201902-0294OC
– volume: 12
  start-page: 2722
  year: 2021
  ident: 10.1016/j.celrep.2022.110639_bib9
  article-title: Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-22890-x
– volume: 25
  start-page: 25
  year: 2000
  ident: 10.1016/j.celrep.2022.110639_bib2
  article-title: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium
  publication-title: Nat. Genet.
  doi: 10.1038/75556
– volume: 79
  start-page: 5022
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib21
  article-title: The immune contexture associates with the genomic landscape in lung adenomatous premalignancy
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-19-0153
– volume: 6
  start-page: 153
  year: 2021
  ident: 10.1016/j.celrep.2022.110639_bib16
  article-title: Extracellular matrix and its therapeutic potential for cancer treatment
  publication-title: Signal. Transduct. Target Ther.
  doi: 10.1038/s41392-021-00544-0
– volume: 6
  start-page: 8258
  year: 2015
  ident: 10.1016/j.celrep.2022.110639_bib17
  article-title: Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms9258
– volume: 154
  start-page: 249
  year: 1999
  ident: 10.1016/j.celrep.2022.110639_bib26
  article-title: Monoclonality of atypical adenomatous hyperplasia of the lung
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)65271-6
– volume: 150
  start-page: 181
  year: 2015
  ident: 10.1016/j.celrep.2022.110639_bib44
  article-title: Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors
  publication-title: Breast Cancer Res. Treat
  doi: 10.1007/s10549-015-3286-6
– volume: 13
  start-page: 3466
  year: 2021
  ident: 10.1016/j.celrep.2022.110639_bib5
  article-title: Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy?
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13143466
– volume: 571
  start-page: 570
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib23
  article-title: Immune evasion before tumour invasion in early lung squamous carcinogenesis
  publication-title: Nature
  doi: 10.1038/s41586-019-1330-0
– volume: 10
  start-page: 2978
  year: 2019
  ident: 10.1016/j.celrep.2022.110639_bib15
  article-title: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-10877-8
SSID ssj0000601194
Score 2.4649634
Snippet To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 110639
SubjectTerms Adenocarcinoma - pathology
Adenocarcinoma of Lung - genetics
CP: Cancer
CT scan density
extracellular matrix
GGO
Humans
lung ground glass lesions
Lung Neoplasms - pathology
Neoplasm Invasiveness - pathology
preinvasive lung adenocarcinoma
Retrospective Studies
Tregs
Tumor Microenvironment
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bq9QwEA5yQPBFvLveiOBrsU2atnlU8XAQ9MkD5y3kMsGV3Vb2dA_4F_zVziTt2tWHffEtpJc0mcnMNPnyDWNvVOvLJkRZOIz2i1q0ZeGkhUJGFUSMLtRpHfLzl-bisv50pa4Wqb4IE5bpgfPAva1a6ckJli3o2kXdlU7Q5pzWXpRWBLK-6PMWP1PZBhOXGW0pC0GYLVG387m5BO7ysNkB0VUKQUD4hnKFL_xSou8_ck__hp9_oygXbun8Hrs7xZP8Xe7HfXYL-gfsds4w-fMh-5U5_TncTCrGh8gx5uPjfjvs-JbgeIuzbtxO0oLAaYWWJ_hWpu7gdBIFK2Dd31gCvfNDYRz-lFPSP75BG8It2jR0lTu_7oetfcQuzz9-_XBRTOkXCq-EHlFmEKzSoYqdhBilawKEoDU0yieB-ACVdZ0vuxqUjNY2zuq28p0H_IkT8jE764cenjLeWBWccG0UwtVSgFbQNk5ElFJwVQUrJufBN37iJqcUGRszg9C-mywyQyIzWWQrVhye-pG5OU7c_57keriXmLVTBeqbmfTNnNK3FWtnrTBTkJKDD3zV-kTzr2clMjiHaWPG9jDsrw2hDDH0Q9u4Yk-yUh0-UqJHUmiGsd0jdTvqxfGVfv0t8YTrUkqhumf_o9vP2R3qSsIsqRfsbNzt4SWGY6N7lWbeb83wNUw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ScienceDirect Free and Delayed Access Journal
  dbid: IXB
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqSkhcEJTXAkVG4hptYsdJfKQVVYUEF6i0N8uPMQTtJlXIVupf6K_G4zzYwKESt8RxEiczmZnY33xDyHtR2rRwnicmRPtJzso0MVxDwr1wzHvj8jgP-flLcXmVf9qIzRE5n3JhEFY52v7BpkdrPbasx7e5vq7r9VcW_l2CdyoZizTnSLvN8yom8W3O5nkW5BvJYj1E7J_gCVMGXYR5Wdh2gMSVjCEkvsCq4QceKhL5LxzVv4Ho33jKAwd18Zg8GiNL-mEY_BNyBM0JeTDUmrx9Su4Gdn8KN6Oy0dbTEP3Rfr9rO7pDYN5B1hvVo9zAUZyrpRHINZB4UMxJCQ1QNzca4e903ujbP9ux_B_dBmtCdbBuwWl2tm7anX5Gri4-fju_TMZCDIkVTPZBeuC0kC7zFQfvuSkcOCclFMLi0mxpHWTaVDatchDca10YLcvMVhbC7xzjz8lx0zbwktBCC2eYKT1jJucMpICyMMwHKTmTZbAifHr5yo4s5VgsY6smONpPNYhMocjUILIVSeazrgeWjnv6n6Fc577IsR0b2u67GpVMZSW3WXw8kLnxskoNw2VhKS1LNXMrUk5aoRYqGy5V33P7d5MSqfA14xKNbqDd_1KINwxBYLCSK_JiUKp5kDz4JhEMcrjvQt0WT7E80tQ_ImO4TDlnonr13yN-TR7iXoQsiTfkuO_2cBqisd68jZ_bb8NYN70
  priority: 102
  providerName: Elsevier
Title Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma
URI https://dx.doi.org/10.1016/j.celrep.2022.110639
https://www.ncbi.nlm.nih.gov/pubmed/35385730
https://www.proquest.com/docview/2648066179
https://pubmed.ncbi.nlm.nih.gov/PMC9033258
https://doaj.org/article/173c102807e94bf980b2287099c20a2d
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9QwFLZKERIXxM6wVEbiGpTYcRIfEKKIqiCVEyPNzfLyDINmEkhnKvoX-NU828m0YVG5RFE2J3mr7c_fI-SFqG1eOc8zg9l-VrI6zwzXkHEvHPPeuDKOQ558rI7n5YeFWOyRsWbr8ANP_9q1C_Wk5v3q5Y_v56_R4F9dYLUsrHoI7JOMBVw7Rt1r5DrGpjqY6smQ8CffHDjOwlQzYwHLxcp6XE_3jwdN4lWk9Z-ErT_T0t_RlZfC1dFtcmvIM-mbpBh3yB60d8mNVHny_B75mbj-KZwNqkc7TzEXpJvtuuvpOsD0Lq2Bo3qQIjgaRm5phHUlSg8aVqjgAVi2ZzqA4eluZ9Nd7MdigHSFvoVq9HUYQnu7bLu1vk_mR-8-vT3OhrIMmRVMblCW4LSQrvANB--5qRw4JyVUwoaJ2to6KLRpbN6UILjXujJa1oVtLGDnjvEHZL_tWnhEaKWFM8zUnjFTcgZSQF0Z5lFKzhQFzAgff76yA2d5KJ2xUiM47atKIlNBZCqJbEay3V3fEmfHFdcfBrnurg2M2_FA139WgwGroua2iJ8HsjReNrlhYZJYSstyzdyM1KNWqCF5SUkJPmp5RfPPRyVSaNthwka30G1PVUAfYkqIPnNGHial2r0kx0gl0D1juxN1m3zF9Ey7_BL5w2XOORPN4_9o9wm5Gd40QpXEU7K_6bfwDLOwjTmIoxe4fb84PIhG9gvEzDcN
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYIL4s3yNBLXaBM7TuIjrai20PZCK-3N8mMMQbtJtWQr9S_0V-NxkmUXDpW4RU6cOJ7xzNj-_A0hH0Vp08J5npgQ7Sc5K9PEcA0J98Ix743L4zrk6Vkxu8i_zMV8jxyOZ2EQVjnY_t6mR2s9lEyH3pxe1vX0Gwtzl-CdSsYizXlxh9wN0UCJ-RuO5webhRYkHMliQkSskGCN8QhdxHlZWKwAmSsZQ0x8gWnDt1xUZPLf8VT_RqJ_Ayq3PNTRI_JwCC3pp771j8keNE_IvT7Z5PVTctPT-1O4GrSNtp6G8I9262W7oktE5m0de6N6EBw4iou1NCK5ehYPiodSQgHUzZVG_DvdXHTtn-uY_48ugjmhOpi34DVXtm7apX5GLo4-nx_OkiETQ2IFk10QHzgtpMt8xcF7bgoHzkkJhbC4N1taB5k2lU2rHAT3WhdGyzKzlYUwn2P8Odlv2gZeElpo4QwzpWfM5JyBFFAWhvkgJWeyDCaEj52v7EBTjtkyFmrEo_1UvcgUikz1IpuQZFPrsqfpuOX5A5Tr5lkk2Y4F7eq7GrRMZSW3Wfw9kLnxskoNw31hKS1LNXMTUo5aoXZ0NryqvuXzH0YlUmE44x6NbqBd_1IIOAxRYDCTE_KiV6pNI3lwTiJY5PDdHXXb-YvdO039I1KGy5RzJqpX_93i9-T-7Pz0RJ0cn319TR7gnYhfEm_Ifrdaw9sQmnXmXRx6vwFe_jrc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+evolution+of+the+tumor+microenvironment+associated+with+progression+from+preinvasive+invasive+to+invasive+human+lung+adenocarcinoma&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Altorki%2C+Nasser+K&rft.au=Borczuk%2C+Alain+C&rft.au=Harrison%2C+Sebron&rft.au=Groner%2C+Lauren+K&rft.date=2022-04-05&rft.issn=2211-1247&rft.eissn=2211-1247&rft.volume=39&rft.issue=1&rft.spage=110639&rft_id=info:doi/10.1016%2Fj.celrep.2022.110639&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-1247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-1247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-1247&client=summon